Jordi Casademont (Jordi Casademont Pou)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Topics

Rheumatoid Arthritis

Dna Methylation

Community Acquired Pneumonia

Top Venues

Journal of personalized medicine

European journal of rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Sandra Clotet-Vidal, M Encarna Saez Prieto, Pol Duch Llorach, Álvaro Santos Gutiérrez, Jordi Casademont, Olga H Torres Bonafonte
Malnutrition, Functional Decline, and Institutionalization in Older Adults after Hospital Discharge Following Community-Acquired Pneumonia. Nutrients 16 (1) (2023)
Sandra Clotet-Vidal, M Encarna Saez Prieto, Pol Duch Llorach, Álvaro Santos Gutiérrez, Jordi Casademont, Olga H Torres Bonafonte
Malnutrition, Functional Decline, and Institutionalization in Older Adults after Hospital Discharge Following Community-Acquired Pneumonia. Nutrients 16 (1) (2023)
Sandra Clotet-Vidal, M Encarna Saez Prieto, Pol Duch Llorach, Álvaro Santos Gutiérrez, Jordi Casademont, Olga H Torres Bonafonte
Malnutrition, Functional Decline, and Institutionalization in Older Adults after Hospital Discharge Following Community-Acquired Pneumonia. Nutrients 16 (1) (2023)
Luis Sainz, Pau Riera, Patricia Moya, Sara Bernal, Jordi Casademont, Cesar Díaz-Torné, Ana Milena Millán, Hye Sang Park, Adriana Lasa, Hèctor Corominas
Clinical Value of IL6R Gene Variants as Predictive Biomarkers for Toxicity to Tocilizumab in Patients with Rheumatoid Arthritis. Journal of personalized medicine 13 (1) (2022)
Luis Sainz, Pau Riera, Patricia Moya, Sara Bernal, Jordi Casademont, Cesar Díaz-Torné, Ana Milena Millán, Hye Sang Park, Adriana Lasa, Hèctor Corominas
Clinical Value of IL6R Gene Variants as Predictive Biomarkers for Toxicity to Tocilizumab in Patients with Rheumatoid Arthritis. Journal of personalized medicine 13 (1) (2022)
Luis Sainz, Pau Riera, Patricia Moya, Sara Bernal, Jordi Casademont, Cesar Díaz-Torné, Ana Milena Millán, Hye Sang Park, Adriana Lasa, Hèctor Corominas
Role of IL6R Genetic Variants in Predicting Response to Tocilizumab in Patients with Rheumatoid Arthritis. Pharmaceutics 14 (9) (2022)
Teresa Franco-Leyva, Olga H Torres, María Encarnación Saez Prieto, Gemma Boera-Carnicero, Álvaro Santos, Sandra Clotet, Daniel Albert-Jares, Yasmin El-Ebiary, Manuela Agustí-Martí, Jordi Casademont, Candido Juarez, Laura Martinez-Martinez
Early differentiated CD28 + CD27 + T lymphocytes as a biomarker for short and long-term outcomes in older patients with pneumonia. Journal of leukocyte biology 112 (5) (2022)
Luis Sainz, Pau Riera, Patricia Moya, Sara Bernal, Jordi Casademont, Cesar Díaz-Torné, Ana Milena Millán, Hye Sang Park, Adriana Lasa, Hèctor Corominas
Clinical Value of IL6R Gene Variants as Predictive Biomarkers for Toxicity to Tocilizumab in Patients with Rheumatoid Arthritis. Journal of personalized medicine 13 (1) (2022)
Luis Sainz, Pau Riera, Patricia Moya, Sara Bernal, Jordi Casademont, Cesar Díaz-Torné, Ana Milena Millán, Hye Sang Park, Adriana Lasa, Hèctor Corominas
Clinical Value of IL6R Gene Variants as Predictive Biomarkers for Toxicity to Tocilizumab in Patients with Rheumatoid Arthritis. Journal of personalized medicine 13 (1) (2022)
Hèctor Corominas, Ivan Castellvi, Pere Domingo, Jordi Casademont
Facing the SARS-CoV-2 (COVID-19) outbreak with IL-6R antagonists. European journal of rheumatology 7 (Suppl 2) (2020)
Cesar Diaz-Torné, María Angels Ortiz, Mónica Sarmiento, César Díaz-López, Hèctor Corominas, Jordi Casademont, Silvia Vidal
Rituximab levels are associated with the B cell homeostasis but not with the clinical response in patients with rheumatoid arthritis. European journal of rheumatology 6 (2) (2019)